Recent advances in animal model experimentation in autism research

Acta Neuropsychiatrica

Volumn 26, Issue 5, 2013, Pages 264-271

  Tania, Mousumi ^a   Khan, Md Asaduzzaman ^a,b   Xia, Kun ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b SOUTHWEST MEDICAL UNIVERSITY   (China)

Author keywords

animal model; autism; genetic manipulations; translational research

Indexed keywords

METHYL CPG BINDING PROTEIN 2; NEUREXIN; NEUROLIGIN; PROTEIN SHANK2; PROTEIN UBE3A; SCAFFOLD PROTEIN; TRANSCRIPTION FACTOR FOXP2; TUBERIN; UNCLASSIFIED DRUG; VALPROIC ACID;

ANIMAL MODEL; AUTISM; CHROMOSOME DELETION; EXPERIMENTAL MODEL; GENE MUTATION; GENETIC VARIABILITY; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL RESEARCH; MOUSE MODEL; MUTAGENESIS; NEUROBIOLOGY; NONHUMAN; OXIDATIVE STRESS; PRENATAL EXPOSURE; PUBLICATION; RAT MODEL; REVIEW; SOCIAL BEHAVIOR; SOCIAL INTERACTION; ANIMAL; ANIMAL EXPERIMENT; AUTISTIC DISORDER; DISEASE MODEL; MOUSE; PROCEDURES; RAT; RESEARCH;

ANIMAL EXPERIMENTATION; ANIMALS; AUTISTIC DISORDER; DISEASE MODELS, ANIMAL; HUMANS; MICE; MUTAGENESIS; NEUROBIOLOGY; RATS; RESEARCH;

EID: 84910631427     PISSN: 09242708     EISSN: 16015215     Source Type: Journal    
DOI: 10.1017/neu.2013.58     Document Type: Review

References (63)

1. KLAUCK SM. Genetics of autism spectrum disorder. Eur J Hum Genet 2006;14:714-720
2. MYERS SM, JOHNSON CP. Council on Children with Disabilities. Management of children with autism spectrum disorders. Pediatrics 2007;120:1162-1182
3. NEWSCHAFFER CJ, CROEN LA, DANIELS J et al. The epidemiology of autism spectrum disorders. Annu Rev Public Health 2007;28:235-258
4. WING L, POTTER D. The epidemiology of autistic spectrum disorders: is the prevalence rising? Ment Retard Dev Disabil Res Rev 2002;8:151-161
5. FOMBONNE E. Epidemiology of pervasive developmental disorders. Pediatr Res 2009;65:591-598
6. HOWLIN P. Practitioner review: psychological and educational treatments for autism. J Child Psychol Psychiatry 1998;39:307-322
7. MONTES G, HALTERMAN JS. Child care problems and employment among families with preschool-aged children with autism in the United States. Pediatrics 2008;122: e202-e208
8. SHASTRY BS. Molecular genetics of autism spectrum disorders. J Hum Genet 2003;48:495-501
9. NOMURA J, TAKUMI T. Animal models of psychiatric disorders that reflect human copy number variation. Neural Plast 2012;2012:589524
10. COOK EH, SCHERER SW. Copy-number variations associated with neuropsychiatric conditions. Nature 2008;455:919-923
11. LANDRIGAN PJ. What causes autism? Exploring the environmental contribution. Curr Opin Pediatr 2010;22: 219-225
12. COURCHESNE E, PIERCE K, SCHUMANN CM et al. Mapping early brain development in autism. Neuron 2007;56: 399-413
13. CHOMIAK T, HU B. Alterations of neocortical development and maturation in autism: insight from valproic acid exposure and animal models of autism. Neurotoxicol Teratol 2013;36:57-66
14. SMILE S, ANAGNOSTOU E. New models for considering the role of medication in the treatment and elucidation of the etiology of autism. Curr Psychiatry Rep 2012;14:726-731
15. MEYZA KZ, DEFENSOR EB, JENSEN AL et al. The BTBR T(1)tf/J mouse model for autism spectrum disorders-in search of biomarkers. Behav Brain Res 2013;251:25-34
16. WATSON KK, PLATT ML. Of mice and monkeys: using nonhuman primate models to bridge mouse- and human-based investigations of autism spectrum disorders. J Neurodev Disord 2012;4:21
17. CRAWLEY JN. Designing mouse behavioral tasks relevant to autistic-like behaviors. Ment Retard Dev Disabil Res Rev 2004;10:248-258
18. NESTLER EJ, HYMAN SE. Animal models of neuropsychiatric disorders. Nat Neurosci 2010;3:1161-1169
19. DANTZER R, KELLEY KW. Autistic children: a neuroimmune perspective. Brain Behav Immun 2008;22:804-805
20. SILVERMAN JL, BABINEAU BA, OLIVER CF, KARRAS MN, CRAWLEY JN. Influence of stimulant-induced hyperactivity on social approach in the BTBR mouse model of autism. Neuropharmacology 2013;68:210-222
21. EY E, LEBLOND CS, BOURGERON T. Behavioral profiles of mouse models for autism spectrum disorders. Autism Res 2011;4:5-16
22. ROULLET FI, WOLLASTON L, DECATANZARO D, FOSTER JA. Behavioral and molecular changes in the mouse in response to prenatal exposure to the anti-epileptic drug valproic acid. Neuroscience 2010;170:514-522
23. LUKOSE R, SCHMIDT E, WOLSKI TP JR, MURAWSKI NJ, KULESZA RJ JR. Malformation of the superior olivary complex in an animal model of autism. Brain Res 2011;398:102-112
24. BAMBINI-JUNIOR V, RODRIGUES L, BEHR GA, MOREIRA JC, RIESGO R, GOTTFRIED C. Animal model of autism induced by prenatal exposure to valproate: behavioral changes and liver parameters. Brain Res 2011;1408:8-16
25. KIM KC, KIM P, GO HS et al. The critical period of valproate exposure to induce autistic symptoms in Sprague-Dawley rats. Toxicol Lett 2011;201:137-142
26. MYCHASIUK R, RICHARDS S, NAKAHASHI A, KOLB B, GIBB R. Effects of rat prenatal exposure to valproic acid on behaviour and neuro-anatomy. Dev Neurosci 2012;34: 268-276
27. KIM KC, KIM P, GO HS et al. Male-specific alteration in excitatory post-synaptic development and social interaction in pre-natal valproic acid exposure model of autism spectrum disorder. J Neurochem 2013;124:832-843
28. FAVRE MR, BARKAT TR, LAMENDOLA D, KHAZEN G, MARKRAM H, MARKRAM K. General developmental health in the VPA-rat model of autism. Front Behav Neurosci 2013;7:88
29. GO HS, KIM KC, CHOI CS et al. Prenatal exposure to valproic acid increases the neural progenitor cell pool and induces macrocephaly in rat brain via a mechanism involving the GSK-3b/b-catenin pathway. Neuropharmacology 2012;63:1028-1041
30. ZHANG Y, SUN Y, WANG F, WANG Z, PENG Y, LI R. Downregulating the canonical Wnt/b-catenin signaling pathway attenuates the susceptibility to autism-like phenotypes by decreasing oxidative stress. Neurochem Res 2012;37:1409-1419
31. SHULTZ SR, MACFABE DF, MARTIN S et al. Intracerebroventricular injections of the enteric bacterial metabolic product propionic acid impairs cognition and sensorimotor ability in the Long-Evans rat: further development of a rodent model of autism. Behav Brain Res 2009;200:33-41
32. MACFABE DF, CAIN NE, BOON F, OSSENKOPP KP, CAIN DP. Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats: relevance to autism spectrum disorder. Behav Brain Res 2011;217: 47-54
33. EL-ANSARY AK, BEN BACHA A, KOTB M. Etiology of autistic features: the persisting neurotoxic effects of propionic acid. J Neuroinflam 2012;9:74
34. BAUDOUIN SJ, GAUDIAS J, GERHARZ S et al. Shared synaptic pathophysiology in syndromic and nonsyndromic rodent models of autism. Science 2012;338: 128-132
35. CHADMAN KK, GONG S, SCATTONI ML et al. Minimal aberrant behavioral phenotypes of neuroligin-3 R451C knockin mice. Autism Res 2008;1:147-158
36. HUNTER JW, MULLEN GP, MCMANUS JR, HEATHERLY JM, DUKE A, RAND JB. Neuroligin-deficient mutants of C. elegans have sensory processing deficits and are hypersensitive to oxidative stress and mercury toxicity. Dis Model Mech 2010;3:366-376
37. ELLEGOOD J, LERCH JP, HENKELMAN RM. Brain abnormalities in a neuroligin3 R451C knockin mouse model associated with autism. Autism Res 2011;4:368-376
38. FISCHER J, HAMMERSCHMIDT K. Ultrasonic vocalizations in mouse models for speech and socio-cognitive disorders: insights into the evolution of vocal communication. Genes Brain Behav 2011;10:17-27
39. RADYUSHKIN K, HAMMERSCHMIDT K, BORETIUS S et al. Neuroligin-3-deficient mice: model of a monogenic heritable form of autism with an olfactory deficit. Genes Brain Behav 2009;8:416-425
40. ETHERTON MR, BLAISS CA, POWELL CM, SUDHOF TC. Mouse neurexin-1alpha deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments. Proc Natl Acad Sci USA 2009;106:17 998-18 003
41. SILVERMAN JL, TURNER SM, BARKAN CL et al. Sociability and motor functions in Shank1 mutant mice. Brain Res 2011;1380:120-137
42. WON H, LEE HR, GEE HY et al. Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function. Nature 2012;486:261-265
43. SCHMEISSER MJ, EY E, WEGENER S et al. Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/ Shank2. Nature 2012;486:255-260
44. BANGASH MA, PARK JM, MELNIKOVA T et al. Enhanced polyubiquitination of Shank3 and NMDA receptor in a mouse model of autism. Cell 2011;145:758-772
45. DEUTSCH SI, PEPE GJ, BURKET JA, WINEBARGER EE, HERNDON AL, BENSON AD. D-cycloserine improves sociability and spontaneous stereotypic behaviors in 4-week old mice. Brain Res 2012;1439:96-107
46. PECA J, FELICIANO C, TING JT et al. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 2011;472:437-442
47. JOHNSON RA, LAM M, PUNZO AM et al. 7,8-dihydroxyflavone exhibits therapeutic efficacy in a mouse model of Rett syndrome. J Appl Physiol 2012;112:704-710
48. DERECKI NC, CRONK JC, LU Z et al. Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature 2012;484:105-109
49. PEARSON BL, DEFENSOR EB, POBBE RL et al. Mecp2 truncation in male mice promotes affiliative social behavior. Behav Genet 2012;2:299-312
50. BOWERS JM, KONOPKA G. The role of the FOXP family of transcription factors in ASD. Dis Markers 2012;33:251-260
51. FUJITA E, TANABE Y, MOMOI MY, MOMOI T. Cntnap2 expression in the cerebellum of Foxp2 (R552H) mice, with a mutation related to speech-language disorder. Neurosci Lett 2012;6:277-280
52. PEN AGARIKANO O, ABRAHAMS BS, HERMAN EI. Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell 2011;147:235-246
53. PEN AGARIKANO O, GESCHWIND DH. What does CNTNAP2 reveal about autism spectrum disorder? Trends Mol Med 2012;18:156-163
54. JANA NR. Understanding the pathogenesis of Angelman syndrome through animal models. Neural Plast 2012;2012: 710943
55. JIANG YH, PAN Y, ZHU L et al. Altered ultrasonic vocalization and impaired learning and memory in Angelman syndrome mouse model with a large maternal deletion from Ube3a to Gabrb3. PLoS One 2010;5:e12278
56. REITH RM, WAY S, MCKENNA J, HAINES K, GAMBELLO MJ. Loss of the tuberous sclerosis complex protein tuberin causes Purkinje cell degeneration. Neurobiol Dis 2011; 43:113-222
57. TSAI PT, HULL C, CHU Y et al. Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice. Nature 2012;488:647-651
58. ZENG LH, RENSING NR, ZHANG B, GUTMANN DH, GAMBELLO MJ, WONG M. Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex. Hum Mol Genet 2011;20:445-454
59. CARSON RP, VAN NIELEN DL, WINZENBURGER PA, ESS KC. Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin. Neurobiol Dis 2012; 45:369-380
60. BUDZISZEWSKA B, LASON W, STECZKOWSKA M, GERGONT A. Value of the experiment for developmental neurology. Przegl Lek 2009;66:958-962
61. FLINT J, SHIFMAN S. Animal models of psychiatric disease. Curr Opin Genet Dev 2008;18:235-240
62. CINQUE C, PONDIKI S, ODDI D et al. Modeling socially anhedonic syndromes: genetic and pharmacological manipulation of opioid neurotransmission in mice. Transl Psychiatry 2012;2:e155
63. PIEDIMONTE LR, WAILES IK, WEINER HL. Tuberous sclerosis complex: molecular pathogenesis and animal models. Neurosurg Focus 2006;20:E4.